🔗 Share this article

Given that the US undertakes unprecedented revisions to its immunization recommendations, one figure appears somewhat surprisingly: Tracy Beth Høeg, a Danish American sports medicine doctor and epidemiologist who first made her name by questioning COVID-19 shots in the global health crisis and has zeroed in on alleged deaths following Covid immunization in her brief tenure at the Food and Drug Administration.

Scheduled Changes to Childhood Vaccine Schedule

Health officials were set to unveil major revisions to the childhood immunization program earlier this month, aligning the US with the Danish vaccine program, sources say – a substantial departure that would place the US at odds with a large portion of the world with no evidence for public health gain. The planned update has been postponed until the next year.

In place of the top vaccines chief, Dr. Høeg is scheduled to speak at the gathering. She was newly appointed acting director of the FDA’s Center for Drug Evaluation and Research (CDER), the fifth appointee to head the office this year.

A New Direction at the FDA

Høeg's temporary position may indicate a strengthened alliance between the pharmaceutical and vaccine branches as Dr. Høeg and Dr. Prasad strengthen their influence at the regulatory agency – and it points to a greater focus upon dismantling previously authorized immunizations at the FDA.

Dr. Høeg has often pushed for halting some childhood vaccine recommendations in the US to become more in line with Denmark's approach, a nation with universal health coverage and a number of inhabitants approximately the size of Wisconsin’s.

So far comments, she has kept her attention on immunizations – typically the purview of Dr. Prasad, head of the FDA’s vaccine center – instead of pharmaceutical oversight.

Doubts Over Background

Høeg has little discernible track record in pharmaceutical research, regulation or management, which has been typical for past directors of the biologics center. She has been employed at the FDA as a key advisor to the commissioner and the vaccine center since March.

“She appears not to have any of the qualifications” for overseeing the pharmaceutical oversight division, remarked Jonathan Howard. “She’s never run a clinical trial. She has no expertise in leading a major agency. She lacks background in pharmaceutical oversight.”

Previous commissioners of the center would “grasp laws and regulations and the underlying principles of drug development”, noted Janet Woodcock. “Clearly, she doesn’t have the sort of resume that prior appointees who ran the center have had.”

This division has an immense workload at the FDA, Woodcock emphasized.

“The public just focuses on the innovative therapies, but the generic program clears numerous off-brand pharmaceuticals. There’s a biosimilars division, OTC medication office and other areas, and each of these must be looked after,” she explained. “The area you overlook, that is precisely what that I always told people is going to come back to haunt you.”

Furthermore, a significant leadership component to the job, which manages over 5,000 personnel. “It’s a massive administrative position, if you execute it properly,” she concluded.

Agency Reaction and Disputed Programs

Regarding concerns about Høeg’s credentials and whether this assignment signifies greater collaboration among regulatory chiefs on vaccines, a press secretary responded that the “inquiries are based on incorrect premises”.

“This background is consistent with the functions of her job,” the representative said, pointing to the period Høeg spent advising the agency head on “pharmaceutical safety and regulatory science, including computational safety modeling and immunization monitoring”.

In her interim role, Dr. Høeg assumes responsibility for the agency head's recently launched priority voucher program, a contentious one-day therapy clearance system that reportedly concerned her predecessors. “How are these drugs being selected for this voucher program? Who makes the decisions?” Howard questioned. “There’s a lot of secrecy going on at the regulatory body right now.”

In general, he stated, “the FDA looks to be trending towards laxer regulations of all drugs, aside from shots.”

Public Track Record on Immunizations

With vaccines, Høeg has a clearer, if concerning, track record, Howard have noted. She released a study using unverified crowd-sourced reports to estimate the frequency of heart inflammation after Covid vaccination. She advised the Florida surgeon general Dr. Joseph Ladapo, who allegedly have altered data to imply COVID-19 vaccinations are pose a greater threat than they are.

Among her “desired changes” for the current federal leadership encompassed changing regulations for recently developed shots and halting “unnecessary” vaccines, she remarked post-election on a audio program. At the FDA, Dr. Høeg has reportedly suggested excluding adolescent males from receiving COVID-19 vaccines.

“She is an thorough true believer who begins with her beliefs and reverse-engineers to fit the evidence in a highly disingenuous, fraudulent way,” Howard said.

Gaining Influence and a “Campaign of Retribution”

Dr. Høeg aligned with fellow contrarians, {like|